CRY News Alert Cryolife (CRY) 11.53 12/25/2014 15:44:33

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cryolife (CRY) 11.53 $CRY

CryoLife Inc. (CRY) in Focus: Stock Moves 7.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 7:37AM CST
CryoLife Inc. (CRY) was a big mover last session, as the company saw its shares rise more than 7% on the day.
INGN: 29.99 (-0.09), CRY: 11.53 (+0.38)

NYSE stocks posting largest percentage increases
AP - Tue Dec 23, 5:07PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
LEN: 43.37 (-0.01), HTZ: 24.38 (-0.09), BBG: 11.46 (-0.24), CHK: 19.84 (-0.45), KN: 22.98 (-0.08), LEN.B: 35.00 (+0.26), LXFR: 14.62 (-1.07), BCEI: 23.25 (-0.62), CRY: 11.53 (+0.38), GCAP: 8.80 (-0.04), USAC: 16.73 (-0.33)

Upgrade Alert for CryoLife (CRY)
Comtex SmarTrend(R) - Tue Dec 23, 6:59AM CST
CryoLife (NYSE:CRY) was upgraded from Neutral to Overweight at Piper Jaffray today. The stock closed yesterday at $10.39 on volume of 160,000 shares, above average daily volume of 110,000. CryoLife (NYSE:CRY) has potential upside of 15.5% based on a current price of $10.39 and analysts' consensus price target of $12.00. The stock should discover initial support at its 50-day moving average (MA) of $10.21 and subsequent support at its 200-day MA of $9.73.
CRY: 11.53 (+0.38)

CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference
PR Newswire - Mon Nov 24, 7:34AM CST
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it will participate in the upcoming 26th Annual Piper Jaffray Healthcare Conference on Wednesday, December 3, 2014 at The New York Palace Hotel in New York City.
CRY: 11.53 (+0.38)

How To YieldBoost CRY To 17.1% Using Options
StockOptionsChannel.com - Wed Nov 19, 10:48AM CST
Shareholders of CryoLife, Inc. looking to boost their income beyond the stock's 1.3% annualized dividend yield can sell the April 2015 covered call at the $10 strike and collect the premium based on the 60 cents bid, which annualizes to an...
CRY: 11.53 (+0.38)

CryoLife Earnings In Retrospect: Down 7.0% in the Last 20 Days (CRY)
Comtex SmarTrend(R) - Mon Nov 17, 2:24PM CST
20 days ago, on October 28th, 2014, CryoLife (NYSE:CRY) reported its earnings. Analysts, on average, expected earnings of $0.04 per share on sales of $37.7 million. CryoLife actually reported earnings of $0.08 per share on sales of $37.1 million, beating EPS estimates by $0.04 and missing revenue estimates by $0.6 million. Shares of CryoLife have slipped from $10.41 to $9.68, representing a loss of 7.0%, since the company reported earnings 20 days ago.
CRY: 11.53 (+0.38)

CryoLife to Present at the Canaccord Genuity 2014 Medical Technology and Diagnostics Forum
PR Newswire - Thu Nov 13, 4:04PM CST
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it will participate in the upcoming Canaccord Genuity 2014 Medical Technology and Diagnostics Forum on Thursday, November 20, 2014 at the Westin Grand Central Hotel in New York.
CRY: 11.53 (+0.38)

Update: CryoLife Q3 2014 Earnings, Book Profit
Andy Batts - at Seeking Alpha - Mon Nov 10, 1:08AM CST

CRY: 11.53 (+0.38)

CryoLife Q3 Earnings Fall, Revenues Rise Y/Y; Shares Tank - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:00PM CST
CryoLife Inc. (CRY) reported adjusted earnings per share of 8 cents in the third quarter of fiscal 2014, lower than the year-ago earnings of 11 cents.
CYNO: 28.00 (-0.04), FLDM: 32.31 (+0.30), CRY: 11.53 (+0.38), ANGO: 19.19 (+0.33)

Organ and Tissue Transplantation Markets - Global Strategic Business Report 2014-2020
M2 - Thu Oct 30, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zx4hg8/organ_and_tissue) has announced the addition of the "Organ and Tissue Transplantation - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Organ and Tissue Transplantation in Number of Procedures. The global and regional markets (except the US) for 'Organ and Tissue Transplantation' in this report are analyzed by the following Product Segments Organ Tranplantation (Heart, Kidneys, Liver, Pancreas, and Lungs) The US market for 'Organ and Tissue Transplantation' in this report is analyzed by the following Product Segments: - Organ Type (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine) - Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), - Bone Graft Transplantation (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report profiles 24 companies including many key and niche players such as: - CryoLife, Inc - Exactech, Inc - Folio Biosciences - K?hler Chemie - LifeCell Corporation - Medtronic, Inc. - Organogenesis, Inc. - Organ Recovery Systems - Organ Transport Systems - XVIVO Perfusion AB Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. MARKET TRENDS 3. TECHNOLOGICAL INNOVATIONS 4. MAJOR ISSUES IMPACTING TRANSPLANTATION MARKET 5. PRODUCT OVERVIEW 6. ARTIFICIAL ORGANS - AN ALTERNATIVE TO SOLID ORGAN TRANSPLANTS 7. PRESERVATION SOLUTIONS & IMMUNOSUPPRESSANT DRUGS 8. REGULATORY ENVIRONMENT 9. PRODUCT DEVELOPMENT/INNOVATIONS 10. RECENT INDUSTRY ACTIVITY 11. FOCUS ON SELECT GLOBAL PLAYERS 12. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. EUROPE 4. ASIA-PACIFIC 5. LATIN AMERICA 6. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 24 - The United States (21) - Europe (2) - - Germany (1) - - Rest of Europe (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/zx...and_tissue
MDT: 74.08 (+0.31), EXAC: 22.68 (+0.24), CRY: 11.53 (+0.38)

CryoLife's (CRY) CEO Patrick Mackin on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Oct 28, 3:12PM CDT

CRY: 11.53 (+0.38)

CryoLife revises guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 12:29PM CDT

CRY: 11.53 (+0.38)

CryoLife (CRY) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Oct 28, 8:55AM CDT

CRY: 11.53 (+0.38)

CryoLife EPS of $0.08
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 7:11AM CDT

CRY: 11.53 (+0.38)

CryoLife Third Quarter 2014 Revenues Increase 2 Percent to $37.1 Million
PR Newswire - Tue Oct 28, 7:04AM CDT
Third Quarter Highlights:
CRY: 11.53 (+0.38)

Notable earnings before Tuesday's open
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 4:30PM CDT

NBL: 48.50 (-0.48), CNX: 34.95 (-0.09), PCG: 54.46 (+1.19), CYNO: 28.00 (-0.04), CRY: 11.53 (+0.38), AET: 89.59 (+0.14), HOT: 80.90 (+0.52), COH: 36.97 (-0.23), MSM: 80.99 (-0.53), SCHN: 22.55 (+0.13), MWV: 45.15 (-0.21), CAS: 7.18 (unch), DD: 74.79 (-0.40), MSO: 4.31 (-0.02), HMC: 30.37 (+0.14), SIRI: 3.48 (unch), HRS: 73.59 (+0.02), AIXG: 10.99 (-0.04), ENTG: 13.34 (-0.02), PFE: 31.42 (-0.03), AGCO: 45.46 (-0.81), FDP: 32.43 (+0.33), ALR: 37.48 (+0.37), GLPI: 29.54 (-0.07), POR: 38.79 (+0.66), NCI: 15.42 (-0.16), AME: 53.98 (+0.19), CPLA: 74.60 (-0.38), SHW: 264.55 (+1.46), SAIA: 55.04 (+0.31), AN: 59.74 (+0.33), NVS: 93.91 (+0.66), PCAR: 69.42 (-0.03), FCX: 22.91 (+0.07), PES: 5.60 (+0.13), CVLT: 53.63 (+0.24), MMC: 58.32 (-0.07), FMER: 18.94 (+0.01), ICON: 33.86 (+0.22), SAVE: 75.68 (+1.52), CMI: 145.82 (+0.09), ACI: 1.78 (+0.01), BP: 38.95 (-0.17), FLWS: 8.07 (+0.18), ECL: 107.18 (-0.27), IPGP: 75.14 (+0.30), MLM: 111.69 (-0.10), RDWR: 22.18 (+0.24), MDSO: 47.27 (+0.15), GLW: 23.22 (+0.08), DIN: 101.87 (-0.40), CNC: 105.96 (+1.03), HCA: 74.89 (-0.11), AXE: 88.60 (-0.08), PH: 130.85 (-0.21), IIVI: 13.97 (+0.25), LH: 107.69 (+0.56), SCOR: 47.60 (+0.56), CIT: 48.20 (-0.12), AMTD: 36.16 (-0.01)

Global Organ and Tissue Transplantation Market
PR Newswire - Thu Oct 23, 4:35PM CDT
This report analyzes the worldwide markets for Organ and Tissue Transplantation in Number of Procedures. The global and regional markets (except the US) for 'Organ and Tissue Transplantation' in this report are analyzed by the following Product Segments - Organ Tranplantation (Heart, Kidneys, Liver, Pancreas, and Lungs). The US market for 'Organ and Tissue Transplantation' in this report is analyzed by the following Product Segments: Organ Type (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine), Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), and Bone Graft Transplantation (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 24 companies including many key and niche players such as -
EXAC: 22.68 (+0.24), CRY: 11.53 (+0.38)

Cryolife declares $0.03 dividend
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 7:43AM CDT

CRY: 11.53 (+0.38)

CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2014
PR Newswire - Thu Oct 23, 7:34AM CDT
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that its Board of Directors has approved a quarterly cash dividend for the fourth quarter 2014 of $0.03 per share of common stock outstanding. The quarterly cash dividend of $0.03 per share will be paid on December 19, 2014 to all common stockholders of record as of December 12, 2014. The ex-dividend date for the quarterly dividend is December 10, 2014.
CRY: 11.53 (+0.38)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ZAKSIMLAB Tests Kombucha and Salmon Snack Pairing in Cafes

Updated Category News Views 48

A fish-based chip beside a fizzy tea mix is an odd little commercial wager, and that is exactly why ZAKSIMLAB's latest move deserves a look. The Seoul food brand launched Salmon Crunch Protein Chips in September, then put the snack next to its powdered kombucha at the 2026 Cafe & Bakery Fair Season 2. This is not a grand earnings story; no sales, pricing, store-count, or...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 135

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 189

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Scalefusion’s Platinum Win Sharpens Its Brand Story

Updated Category News Views 14

A Film Is Not a Balance Sheet A slick brand film cannot patch a leaky product, but it can make a complicated platform easier to remember. That is the sensible takeaway from Scalefusion’s Platinum Level win at the 2026 MarCom Awards for “One Platform. One Agent. We are Scalefusion.” The recognition is for creative execution, not commercial performance, and anybody...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 172

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 194

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
Mike Blyth’s Hall of Fame Honors a Builder’s Legacy

Updated Category News Views 147

Recognition earned in the hangar, not a boardroom Aircraft design has a ruthless way of exposing empty talk, which is why Mike Blyth’s November 11 induction into the EAA Homebuilders Hall of Fame carries real weight. The Experimental Aircraft Association’s honor, presented in the Eagle Hangar at the EAA Aviation Museum in Oshkosh, Wisconsin, recognizes a career built...

Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 81

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 89

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 237

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading

Top 5 Most Recently Viewed Articles

Olo Inc. Under Investigation for Potential Fiduciary Violations

Updated Category News Views 255

Olo Inc. Faces Investigation Over Fiduciary Duties Olo Inc. is currently under investigation by legal authorities due to possible breaches of fiduciary duty by its directors and management. This scrutiny follows Olo's announcement regarding a major acquisition deal with investment firm Thoma Bravo, valued at around $2 billion. Details of the Investigation The focus of the...

Continue Reading
Join MT Højgaard Holding's Conference Call on FY 2024 Results

Updated Category News Views 115

MT Højgaard Holding A/S Conference Call Overview MT Højgaard Holding is set to release its annual report for the fiscal year 2024 on a chosen date. Following this release, a conference call will take place where the management team will delve into the company’s performance and projections for the future. This session aims to provide insights into the results for the...

Continue Reading
ClearValue Consulting Partners with Restb.ai for Advanced Appraisals

Updated Category News Views 77

Unlocking Efficiency in Appraisal Reviews ClearValue Consulting, a leader in innovative valuation solutions, has announced an exciting new partnership with Restb.ai, a prominent name in AI-powered computer vision. This collaboration is set to redefine the appraisal review landscape, bringing in advanced technologies to streamline processes and enhance quality. The Impact...

Continue Reading
BrightSphere's Transformation: New Name and Leadership Direction

Updated Category News Views 393

BrightSphere Investment Group Inc. (NYSE: BSIG) announced its rebranding to Acadian Asset Management back in early 2025, marking a major shift in strategy. This wasn't just a name change; it was the end of their multi-boutique model and the start of a more streamlined focus on asset management. They offloaded six out of seven affiliates to zero in on core...

Continue Reading
Why Super Micro Computer’s Growth Could Still Continue

Updated Category News Views 339

Super Micro Computer (NASDAQ: SMCI) kicked off 2024 like a rocket, watching its stock explode by an eye-popping 188% in the first half. It was a remarkable performance that even left tech giants scrambling for a second look. The surge stemmed largely from surging demand for their cutting-edge workstations and servers—essential cogs in the booming artificial intelligence...

Continue Reading